[Video Profile] Interview with Craig Davenport, President & CEO of Endocare

Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and cryotherapy. Treatment depends on factors including the patient’s age, the stage of the cancer and the presence of other...

[Video Profile] Interview with Ron Andrews, President & CEO of Clarient

Clarient provides access to technologies and services for the characterization, assessment and treatment of cancer. The company offers a full range of diagnostic technologies and services for the clinical cancer diagnostics industry including immunohistochemistry, flow cytometry, in-house molecular testing,...

[Video Profile] Interview with Jon Garfield, CEO of Clearant

Orthopedic tissue market is large and growing Technological advancements in the repair and replacement of damaged bone and soft tissue has driven the growth of the orthopedic allograft market. The market is worth an estimated $1 billion, and is growing at 15-20% annually. Allograft procedures use tissues...

[Video Profile] Interview with Mitchell Seyedin, President & CEO of ISTO Technologies

Within the sports medicine market, repair of cartilage injuries represents one of the greatest unmet medical needs. In the U.S., approximately 500,000 cartilage lesions are detected in knee joints each year. Because adult cartilage cells cannot fully regenerate and repair injuries, lesions left untreated...

[Video Profile] Interview with Raymond W. Cohen, CEO of Symphony Medical

Postoperative Atrial Fibrillation is an abnormal, irregular heart rhythm where electrical signals are generated apparently randomly throughout the upper chambers (atria) of the heart. The condition is the most common and significant complication of the more than one million cardiothoracic surgery procedures...

[Video Profile] Interview with John Seaberg, CEO of NeoChord

This interview with John Seaberg, CEO of NeoChord, is the first of many filmed earlier this month at the OMP Finance Forum. NeoChord aims to significantly improve the surgical repair of mitral valve regurgitation through the use of minimally invasive surgical techniques for the implantation of artificial...